(Q83961679)
Statements
CYP2C9 genotyping in acenocoumarol treatment: is it a cost-effective addition to international normalized ratio monitoring? (English)
Tom Schalekamp
Gerard J J Boink
Loes E Visser
Bruno H Ch Stricker
Anthonius de Boer